Non small cell lung cancer medical therapy stage I: Difference between revisions
Line 34: | Line 34: | ||
{{familytree | G01 | | G02 | | G03 | | G04 | | G01=Yes|G02=No|G03=Yes|G04=No}} | {{familytree | G01 | | G02 | | G03 | | G04 | | G01=Yes|G02=No|G03=Yes|G04=No}} | ||
{{familytree | |!| | | |!| | | |!| | | |!| | | |}} | {{familytree | |!| | | |!| | | |!| | | |!| | | |}} | ||
{{familytree | H01 | | H02 | | H03 | | H04 | | | | H01=[[Non small cell carcinoma of the lung | {{familytree | H01 | | H02 | | H03 | | H04 | | | | H01=[[Non small cell carcinoma of the lung medical therapy stage III|Click here for the stage III treatment]]|H02=Is the tumor operable?|H03=[[Non small cell carcinoma of the lung medical therapy stage III|Click here for the stage III treatment]]|H04=Is the tumor operable?}} | ||
{{familytree | | | |,|-|^|-|.| | | |,|-|^|-|.| | |}} | {{familytree | | | |,|-|^|-|.| | | |,|-|^|-|.| | |}} | ||
{{familytree | | | I01 | | I02 | | I03 | | I04 | | | I01=Yes|I02=No|I03=Yes|I04=No}} | {{familytree | | | I01 | | I02 | | I03 | | I04 | | | I01=Yes|I02=No|I03=Yes|I04=No}} | ||
{{familytree | | | |!| | | |!| | | |!| | | |!| | | |}} | {{familytree | | | |!| | | |!| | | |!| | | |!| | | |}} | ||
{{familytree | | | J01 | | J02 | | J03 | | J04 | | | J01=Surgical resection + [[lymph node]] dissection|J02=[[ | {{familytree | | | J01 | | J02 | | J03 | | J04 | | | J01=Surgical resection + [[lymph node]] dissection|J02=[[Non small cell carcinoma of the lung medical therapy radiation therapy|Radiation therapy with stereotactic ablative radiotherapy]]|J03=Surgical resection + [[lymph node]] dissection|J04=Does the patient presents metastasis to ipsilateral peribronchial and/or hiliar nodesand intrapulmonar nodes (N1)?}} | ||
{{familytree | | | | | | | | | | | | | |,|-|^|-|.| | |}} | {{familytree | | | | | | | | | | | | | |,|-|^|-|.| | |}} | ||
{{familytree | | | | | | | | | | | | | K01 | | K02 | | |K01=Yes|K02=No}} | {{familytree | | | | | | | | | | | | | K01 | | K02 | | |K01=Yes|K02=No}} | ||
{{familytree | | | | | | | | | | | | | |!| | | |!| | | |}} | {{familytree | | | | | | | | | | | | | |!| | | |!| | | |}} | ||
{{familytree | | | | | | | | | | | | | L01 | | L02 | | | L01=[[Non small cell carcinoma of the lung chemotherapy|Chemotherapy]] + [[Non small cell carcinoma of the lung radiation therapy|radiation therapy]]|L02=[[Non small cell carcinoma of the lung medical therapy | {{familytree | | | | | | | | | | | | | L01 | | L02 | | | L01=[[Non small cell carcinoma of the lung chemotherapy|Chemotherapy]] + [[Non small cell carcinoma of the lung radiation therapy|radiation therapy]]|L02=[[Non small cell carcinoma of the lung medical therapy radiation therapy|Radiation therapy with stereotactic ablative radiotherapy]]<br>Adjuvant [[Non small cell carcinoma of the lung chemotherapy|Chemotherapy]] should be added for high-risk stages}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 16:14, 24 June 2014
Non Small Cell Lung Cancer Microchapters |
Differentiating Non Small Cell Lung Cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Non small cell lung cancer medical therapy stage I On the Web |
American Roentgen Ray Society Images of Non small cell lung cancer medical therapy stage I |
Non small cell lung cancer medical therapy stage I in the news |
Directions to Hospitals Treating Non small cell carcinoma of the lung |
Risk calculators and risk factors for Non small cell lung cancer medical therapy stage I |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]
Overview
Medical Therapy for Stage I Non-Small Cell Lung Cancer
Shown below is the algorithm on the treatment of the stage I non-small cell lung cancer based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[1]
In the tumor central o peripheral? | |||||||||||||||||||||||||||||||||||||||||||
Peripheral | Central | ||||||||||||||||||||||||||||||||||||||||||
Is the tumor T1 or T2a? | |||||||||||||||||||||||||||||||||||||||||||
T1ab, N0 | T2a, N0 | T1ab-2a, N0 | |||||||||||||||||||||||||||||||||||||||||
Perform a pretreatment evaluation
| Perform a pretreatment evaluation | ||||||||||||||||||||||||||||||||||||||||||
Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | ||||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Click here for the stage III treatment | Is the tumor operable? | Click here for the stage III treatment | Is the tumor operable? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Surgical resection + lymph node dissection | Radiation therapy with stereotactic ablative radiotherapy | Surgical resection + lymph node dissection | Does the patient presents metastasis to ipsilateral peribronchial and/or hiliar nodesand intrapulmonar nodes (N1)? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||
Chemotherapy + radiation therapy | Radiation therapy with stereotactic ablative radiotherapy Adjuvant Chemotherapy should be added for high-risk stages | ||||||||||||||||||||||||||||||||||||||||||